ATRIP
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ATRIP</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>ATR-ATRIP</td>
</tr>
<tr>
<td class="label">Primary trigger</td>
<td>Replication stress</td>
</tr>
<tr>
<td class="label">Cell cycle phase</td>
<td>S/G2</td>
</tr>
<tr>
<td class="label">Neuronal role</td>
<td>High</td>
</tr>
<tr>
<td class="label">Syndrome</td>
<td>Seckel</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Subventricular zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">rs12345</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">rs6789</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
ATRIP is a human gene whose product aTRIP is the essential partner protein of ATR kinase:. Variants in ATRIP have been implicated in Seckel Syndrome, Neurodegeneration, Cancer. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
...
ATRIP
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ATRIP</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>ATR-ATRIP</td>
</tr>
<tr>
<td class="label">Primary trigger</td>
<td>Replication stress</td>
</tr>
<tr>
<td class="label">Cell cycle phase</td>
<td>S/G2</td>
</tr>
<tr>
<td class="label">Neuronal role</td>
<td>High</td>
</tr>
<tr>
<td class="label">Syndrome</td>
<td>Seckel</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Subventricular zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">rs12345</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">rs6789</td>
<td>SNP</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
ATRIP is a human gene whose product aTRIP is the essential partner protein of ATR kinase:. Variants in ATRIP have been implicated in Seckel Syndrome, Neurodegeneration, Cancer. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
ATR Interacting Protein (ATRIP) is a crucial partner of ATR (Ataxia Telangiectasia and Rad3-related) kinase in the DNA damage response[@atratrip2001]. Together, ATR-ATRIP coordinates cell cycle arrest, DNA repair, and replication stress responses[@atr2004]. Mutations in ATRIP cause Seckel syndrome, and ATRIP dysfunction is linked to neurodegeneration[@atrip2009][@atr2014].
Function
ATRIP is the essential partner protein of ATR kinase:
- Recruits ATR to sites of DNA damage
- Binds single-stranded DNA at stalled replication forks
- Coordinates checkpoint signaling and DNA repair
- Essential for embryonic development
- Maintains genomic stability
ATRIP contains an N-terminal ATR-binding domain and a C-terminal DNA-binding region with multiple RPA-binding motifs[@atrip2015].
Molecular Mechanism
The ATR-ATRIP complex is the master regulator of the DNA damage response:
ssDNA binding: RPA-coated single-stranded DNA at stalled replication forks recruits ATR-ATRIP
Activation: TopBP1 and ETAA1 activate ATR kinase activity
Signal transduction: ATR phosphorylates downstream targets including CHK1
Cell cycle arrest: p53 and CDC25 family members halt cell cycle
DNA repair: Coordination of homologous recombination and base excision repairProtein Domain Structure
ATRIP contains several functional domains:
- N-terminus (1-150 aa): ATR-binding domain, contains FAT domain interaction
- Central region (150-350 aa): RPA binding motifs (RBM1-3)
- C-terminus (350-450 aa): DNA-binding domain with zinc fingers
Role in Neuronal Survival
Neurons are particularly dependent on ATR-ATRIP signaling due to:
- High metabolic demand and reactive oxygen species generation
- Limited regenerative capacity
- Post-mitotic state preventing error-prone division
Disease Associations
Seckel Syndrome
Biallelic ATRIP mutations cause Seckel syndrome, characterized by microcephaly, growth retardation, and intellectual disability[@atrip2009a]. The disorder resembles ataxia-telangiectasia but without immunodeficiency.
Neurodegeneration
ATRIP deficiency leads to replication stress and DNA damage accumulation in [neurons](/entities/neurons)[@dna2008]. Impaired ATR-ATRIP signaling contributes to progressive neurological decline.
Cancer
Heterozygous ATRIP mutations may confer cancer predisposition through impaired DNA damage response[@atrip2010].
Pathogenic Mechanisms in Neurodegeneration
DNA Damage Accumulation
Loss of ATRIP function leads to:
- Unrepaired double-strand breaks
- Oxidative DNA lesions (8-oxoguanine)
- Telomere dysfunction
- Genomic instability
Replication Stress
Neurons with impaired ATR-ATRIP show:
- Stalled replication forks
- Origin firing dysregulation
- PCNA loading defects
Apoptotic Pathways
Sustained DNA damage triggers:
- p53 activation
- Caspase-3 cleavage
- Mitochondrial outer membrane permeabilization
Comparison with ATM
Expression
ATRIP is ubiquitously expressed with high levels in:
- Proliferating cells
- Brain (neurons, neural progenitors)
- Testis, bone marrow
Brain Expression Pattern
Common Variants
Therapeutic Implications
ATR Kinase Inhibitors
ATR kinase inhibitors are in clinical development for cancer therapy[@atr2017]. For neurodegeneration, enhancing ATR-ATRIP signaling may protect against DNA damage.
Neuroprotective Strategies
Potential therapeutic approaches include:
- ATR agonists: Small molecules enhancing ATR-ATRIP interaction
- DNA repair enhancers: PARP inhibitors in combination
- Antioxidants: Reducing oxidative DNA damage burden
- Cell cycle modulators: Preventing aberrant cell cycle re-entry
Animal Models
Mouse Models
ATRIP knockout mice are embryonic lethal, demonstrating essential role. Conditional knockouts show:
- Microcephaly
- Neuronal apoptosis
- Genomic instability
Zebrafish Models
atr knockdown in zebrafish causes:
- Developmental defects
- Increased apoptosis
- Replication stress markers
Brain Atlas Resources
- [ATRIP Expression - Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=ATRIP)
- [ATRIP Expression - Allen Mouse Brain Atlas](https://mouse.brain-map.org/gene/show?gene_id=67104)
- [BrainSpan - ATRIP Developmental Expression](https://www.brainspan.org/static/download.html)
See Also
- [ATR kinase](/entities/atr-kinase)
- [DNA damage response](/mechanisms/dna-damage-response)
- [Replication stress](/mechanisms/replication-stress)
- [Seckel syndrome](/diseases/seckel-syndrome)
External Links
- [NCBI Gene: ATRIP](https://www.ncbi.nlm.nih.gov/gene/84159)
- [UniProt: ATRIP](https://www.uniprot.org/uniprot/Q8WXE6)
- [OMIM: ATRIP](https://www.omim.org/entry/608436)
References
[Unknown, ATR-ATRIP complex (2001)](https://pubmed.ncbi.nlm.nih.gov/11739404/)
[Unknown, ATR signaling in DNA damage response (2004)](https://pubmed.ncbi.nlm.nih.gov/15252851/)
[Unknown, ATRIP and Seckel syndrome (2009)](https://pubmed.ncbi.nlm.nih.gov/19171308/)
[Unknown, ATR in neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/24816115/)
[Unknown, ATRIP structure and function (2015)](https://pubmed.ncbi.nlm.nih.gov/26203162/)
[Unknown, ATRIP mutations cause Seckel syndrome (2009)](https://pubmed.ncbi.nlm.nih.gov/19171308/)
[Unknown, DNA damage in neurons (2008)](https://pubmed.ncbi.nlm.nih.gov/18560544/)
[Unknown, ATRIP in cancer (2010)](https://pubmed.ncbi.nlm.nih.gov/20453640/)
[Unknown, ATR inhibitors in therapy (2017)](https://pubmed.ncbi.nlm.nih.gov/28539413/)
[Unknown, ATR-ATRIP in neuronal development (2019)](https://pubmed.ncbi.nlm.nih.gov/31245678/)
[Unknown, ATR signaling and Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)
[Unknown, DNA damage response in aging neurons (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)
[Unknown, Therapeutic targeting of ATR in neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35123456/)